Pulmonary Hypertension in Parenchymal Lung Disease

被引:6
作者
Ruggiero, Rosechelle M. [1 ]
Bartolome, Sonja [1 ]
Torres, Fernando [1 ,2 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Div Pulm & Crit Care Med, Dallas, TX 75390 USA
[2] Univ Texas SW Med Ctr Dallas, Lung Transplant & Pulm Hypertens Program, Dallas, TX 75390 USA
关键词
Pulmonary hypertension; Interstitial lung disease; Chronic obstructive pulmonary disease; Idiopathic pulmonary fibrosis; OBSTRUCTIVE SLEEP-APNEA; POSITIVE AIRWAY PRESSURE; TERM OXYGEN-THERAPY; PLACEBO-CONTROLLED TRIAL; ARTERIAL-HYPERTENSION; COR-PULMONALE; WALK DISTANCE; COPD PATIENTS; GAS-EXCHANGE; SARCOIDOSIS;
D O I
10.1016/j.hfc.2012.04.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The pathophysiology of pulmonary hypertension (PH) in parenchymal lung diseases is partially related to hypoxic pulmonary vasoconstriction. PH treatment is controversial for these patients. This article focuses on group III PH, namely PH attributable to lung diseases and/or hypoxia. Group III includes chronic obstructive pulmonary disease and interstitial lung diseases, the most common parenchymal lung diseases associated with PH. It also includes sleep-disordered breathing and hypoventilation from any cause. Other parenchymal lung diseases associated with PH, namely sarcoidosis and systemic vasculitides (group V), are discussed. The data describing PH in specific parenchymal diseases are reviewed.
引用
收藏
页码:461 / +
页数:15
相关论文
共 105 条
  • [1] Daytime pulmonary hypertension in patients with obstructive sleep apnea - The effect of continuous positive airway pressure on pulmonary hemodynamics
    Alchanatis, M
    Tourkohoriti, G
    Kakouros, S
    Kosmas, E
    Podaras, S
    Jordanoglou, JB
    [J]. RESPIRATION, 2001, 68 (06) : 566 - 572
  • [2] Phosphodiesterase type 5 and high altitude pulmonary hypertension
    Aldashev, AA
    Kojonazarov, BK
    Amatov, TA
    Sooronbaev, TM
    Mirrakhimov, MM
    Morrell, NW
    Wharton, J
    Wilkins, MR
    [J]. THORAX, 2005, 60 (08) : 683 - 687
  • [3] Characterization of high-altitude pulmonary hypertension in the Kyrgyz: Association with angiotensin-converting enzyme genotype
    Aldashev, AA
    Sarybaev, AS
    Sydykov, AS
    Kalmyrzaev, BB
    Kim, EV
    Mamanova, LB
    Maripov, R
    Kojonazarov, BK
    Mirrakhimov, MM
    Wilkins, MR
    Morrell, NW
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (10) : 1396 - 1402
  • [4] Sildenafil improves hemodynamic parameters in COPD - an investigation of six patients
    Alp, S.
    Skrygan, M.
    Schmidt, W. E.
    Bastian, A.
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2006, 19 (06) : 386 - 390
  • [5] Prevalence and prevention of venous thromboembolism in patients with acute exacerbations of COPD
    Ambrosetti, M
    Ageno, W
    Spanevello, A
    Salerno, M
    Pedretti, RFE
    [J]. THROMBOSIS RESEARCH, 2003, 112 (04) : 203 - 207
  • [6] [Anonymous], 1980, ANN INTERN MED, V93, P391
  • [7] Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease
    Arcasoy, SM
    Christie, JD
    Ferrari, VA
    Sutton, MS
    Zisman, DA
    Blumenthal, NP
    Pochettino, A
    Kotloff, RM
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (05) : 735 - 740
  • [8] Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation
    Arcasoy, SM
    Christie, JD
    Pochettino, A
    Rosengard, BR
    Blumenthal, NP
    Bavaria, JE
    Kotloff, RM
    [J]. CHEST, 2001, 120 (03) : 873 - 880
  • [9] A placebo-controlled trial of prostacyclin in acute respiratory failure in COPD
    Archer, SL
    Mike, D
    Crow, J
    Long, W
    Weir, EK
    [J]. CHEST, 1996, 109 (03) : 750 - 755
  • [10] Pulmonary hypertension in obstructive sleep apnoea:: effects of continuous positive airway pressure -: A randomized, controlled cross-over study
    Arias, MA
    García-Río, F
    Alonso-Fernández, A
    Martínez, I
    Villamor, J
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 (09) : 1106 - 1113